AU1152001A - Diagnostic test for cephalic pain - Google Patents

Diagnostic test for cephalic pain

Info

Publication number: AU1152001A
Authority: AU; Australia
Prior art keywords: diagnostic test; cephalic pain; cephalic; pain; diagnostic
Prior art date: 1999-10-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU11520/01A

Inventor

Linda Catherine Mccarthy

Ian James Purvis

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Glaxo Group Ltd

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-19

Filing date

2000-10-19

Publication date

2001-04-30

2000-10-19 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2001-04-30 Publication of AU1152001A publication Critical patent/AU1152001A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2561/00—Nucleic acid detection characterised by assay method
- C12Q2561/101—Taqman
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Analytical Chemistry (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Biotechnology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pathology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

AU11520/01A 1999-10-19 2000-10-19 Diagnostic test for cephalic pain Abandoned AU1152001A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9924717		1999-10-19
GBGB9924717.3A GB9924717D0 (en)	1999-10-19	1999-10-19	Diagnostic
PCT/GB2000/004024 WO2001029255A2 (en)	1999-10-19	2000-10-19	Diagnostic test for cephalic pain

Publications (1)

Publication Number	Publication Date
AU1152001A true AU1152001A (en)	2001-04-30

Family

ID=10862998

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU79356/00A Abandoned AU7935600A (en)	1999-10-19	2000-10-19	Cephalic pain susceptibility marker
AU11520/01A Abandoned AU1152001A (en)	1999-10-19	2000-10-19	Diagnostic test for cephalic pain

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU79356/00A Abandoned AU7935600A (en)	1999-10-19	2000-10-19	Cephalic pain susceptibility marker

Country Status (5)

Country	Link
EP (1)	EP1226276A2 (en)
JP (1)	JP2003512062A (en)
AU (2)	AU7935600A (en)
GB (1)	GB9924717D0 (en)
WO (2)	WO2001029255A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU1036801A (en) *	1999-10-19	2001-04-30	Glaxo Group Limited	Agent for treating cephalic pain
AU1037301A (en) *	1999-10-19	2001-04-30	Glaxo Group Limited	Therapy of cephalic pain
JP7107882B2 (en) *	2019-04-22	2022-07-27	ジェネシスヘルスケア株式会社	How to Determine Migraine Risk

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4761371A (en) *	1985-02-12	1988-08-02	Genentech, Inc.	Insulin receptor
GB9104890D0 (en) *	1991-03-08	1991-04-24	Glaxo Group Ltd	Compositions
WO1995031542A1 (en) *	1994-05-12	1995-11-23	Otsuka Pharmaceutical Co. Ltd.	Mutant human insulin receptor dna
US5677279A (en) *	1996-12-16	1997-10-14	Amylin Pharmaceuticals, Inc.	Methods and compositions for treating pain with amylin or agonists thereof

1999
- 1999-10-19 GB GBGB9924717.3A patent/GB9924717D0/en not_active Ceased
2000
- 2000-10-19 AU AU79356/00A patent/AU7935600A/en not_active Abandoned
- 2000-10-19 EP EP00972963A patent/EP1226276A2/en not_active Withdrawn
- 2000-10-19 WO PCT/GB2000/004024 patent/WO2001029255A2/en not_active Ceased
- 2000-10-19 JP JP2001532236A patent/JP2003512062A/en active Pending
- 2000-10-19 WO PCT/GB2000/004050 patent/WO2001029256A2/en not_active Ceased
- 2000-10-19 AU AU11520/01A patent/AU1152001A/en not_active Abandoned

Also Published As

Publication number	Publication date
AU7935600A (en)	2001-04-30
WO2001029255A9 (en)	2002-02-07
WO2001029255A2 (en)	2001-04-26
WO2001029256A2 (en)	2001-04-26
EP1226276A2 (en)	2002-07-31
GB9924717D0 (en)	1999-12-22
JP2003512062A (en)	2003-04-02
WO2001029255A3 (en)	2002-05-16
WO2001029256A3 (en)	2002-06-13

Publication	Publication Date	Title
AU7984100A (en)	2001-04-24	Device for heart measurement
GB9910938D0 (en)	1999-07-14	Diagnostic apparatus
AU6210199A (en)	2001-04-30	Test device
AU6930998A (en)	1998-11-11	Anatomical probe
AU1050401A (en)	2001-05-08	Device for cardiac therapy
AUPQ886100A0 (en)	2000-08-10	Diagnostic test
AU7697000A (en)	2001-04-24	Stereotactic apparatus
AUPP662698A0 (en)	1998-11-12	Examination device
AU3716500A (en)	2000-09-21	Interface independent test system
AU2679400A (en)	2000-09-04	Mat for retaining surgical instruments
AU1163101A (en)	2001-05-30	Diagnostic methods
AU5672300A (en)	2000-12-12	Diagnostic device
AU1554401A (en)	2001-06-12	X-ray tester
AUPQ015299A0 (en)	1999-05-27	Ph probe
AU1152001A (en)	2001-04-30	Diagnostic test for cephalic pain
AU4416500A (en)	2000-11-14	Tomographic system
AU6000600A (en)	2001-02-05	Diagnostic method
AU2194801A (en)	2001-06-25	Diagnostic method
AU4755800A (en)	2000-12-05	Diagnostic system
AU6509698A (en)	1998-10-22	Methods for clinical diagnosis
AU6925800A (en)	2001-04-30	Autogrid analysis
AU7803100A (en)	2001-04-23	Test apparatus
AU1371401A (en)	2001-05-30	Disposable test device
AU3269101A (en)	2001-06-06	Diagnostic test for hemochromatosis
AU4048201A (en)	2001-06-25	Test device

Legal Events

Date	Code	Title	Description
2002-06-20	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase